• ABOUT
  • TEAM
  • SERVICES
  • RESULTS
  • MEDIA & EVENTS

Dr. Daniel Sieiro Mosti Joins Plexus Ventures as Scientific Associate for Gene and Cell Therapies

by plexusventures_h3tnl0 | Sep 1, 2019 | Uncategorized

Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Dr. Daniel Sieiro Mosti as Scientific Associate. Dr. Sieiro is a former research fellow at Harvard Medical School where he focused on the genetic basis of tissue development in health and...

Plexus Ventures Appoints Pierfrancesco Maschio as Director for Southern Europe

by plexusventures_h3tnl0 | Mar 1, 2019 | Uncategorized

Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Pierfrancesco Maschio, based in Milan, as Director for Southern Europe.  Pierfrancesco is a long-time entrepreneur who has successfully built his Ricerchimica healthcare business development...

Plexus Ventures Assists Fujifilm Kyowa Kirin Biologics in Partnering with Mylan of Humira® Biosimilar

by plexusventures_h3tnl0 | Apr 24, 2018 | Uncategorized

Tokyo, Japan – Plexus Ventures is pleased to announce the successful conclusion of an out-licensing project of its client Fujifilm Kyowa Kirin Biologics Co., Ltd. Plexus Ventures provided professional services to Fujifilm Kyowa Kirin Biologics to partner the European...

Celon Pharma has positively concluded the decentralised procedure (DCP) for Salmex® on Scandinavian markets

by plexusventures_h3tnl0 | Nov 30, 2017 | Uncategorized

Plexus Ventures would like to share successful news from Celon Pharma. Additional details are provided in Celon’s press release (Warsaw, 30.11.2017): • Finalisation of the DCP opens new perspectives for the Company in terms of export to the market as big as approx. 3...
« Older Entries
Next Entries »

Recent Posts

  • Plexus Ventures Assists First Pharma in Successful Completion of Business Sale to a Strategic Buyer
  • Plexus Ventures Assists Sanofi Consumer Health to Divest a Product Portfolio in Australia and South-East Asia to Phoenix Labs
  • Plexus Ventures Assists Elthera AG in the Licensing of its First-in-Class Antibody
  • Celon Pharma enters agreement with Zydus Lifesciences Ltd.
  • Mindpax engages Plexus Ventures as Exclusive Advisor to Partner its Digital Platform for Severe Mental Illnesses

Recent Comments

    Collaborating with clients to grow their businesses; committing our experience, resources and time to their success.

    Business Builders in Healthcare

    Contact Us
    • Follow

    About Us

    Our Team

    Areas of Expertise

    Project Portfolio

    What’s Trending